Thomas W. Doebber - Concepedia

Author

Thomas W. Doebber

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

T W Doebber, T. DOEBBER, T. W. DOEBBER, T. W. Doebber, T.W. DOEBBER, T.W. Doebber, THOMAS DOEBBER, Thomas Doebber, Thomas W Doebber, Thomas W. Doebber

Publications

11.3K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy

About

Thomas W. Doebber is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	33	3.9K
2	Biochemistry	22	26	3K
3	Health Sciences	12	12	2.2K
4	Natural Sciences	10	10	717
5	Allergy	1	1	38

Thomas W. Doebber

Publications

11.2K

Citations

H-Index

Page 1

	Year	Citations
Role of AMP-activated protein kinase in mechanism of metformin action Gaochao Zhou, Robert P. Myers, Ying Li, Journal of Clinical Investigation	2001	5.3K
Role of AMP-activated protein kinase in mechanism of metformin action Gaochao Zhou, Robert P. Myers, Ying Li, Journal of Clinical Investigation Metformin ActionCytoskeletonCellular PhysiologyMetabolic SyndromeSignaling Pathway	2001	632
Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects Joel P. Berger, Mark D. Leibowitz, Thomas W. Doebber, Journal of Biological Chemistry	1999	411
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Philip J. Bailey, Chhabi Biswas, Catherine A. Cullinan, Endocrinology Insulin SignalingDb/db MiceMolecular PharmacologyMetabolic SyndromeInsulin Delivery	1996	380
Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator Joel P. Berger, Ann Petro, Karen L. MacNaul, Molecular Endocrinology Lipid PeroxidationMolecular BiologyRedox BiologyOxidative StressMetabolic Syndrome	2003	321
Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. studies with paf-receptor antagonist kadsurenone Thomas W. Doebber, Margaret Wu, James C. Robbins, Biochemical and Biophysical Research Communications InflammationThrombosisHypertensionMolecular PharmacologyEndotoxin-induced Hypotension	1985	294
Targeted Disruption of the Tumor Necrosis Factor-α Gene: Metabolic Consequences in Obese and Nonobese Mice John Ventre, Thomas W. Doebber, Margaret Wu, Diabetes Metabolic DisorderNonobese MicePathologyMetabolic RemodelingInsulin Signaling	1997	277
Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression Linda Kelly, Pasquale P. Vicario, G M Thompson, Endocrinology	1998	271
Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1 Guoqiang Jiang, Zhihua Li, Franklin Liu, Journal of Clinical Investigation PharmacotherapyFatty Liver DiseaseObesityMetabolic SyndromeFatty Acids	2005	255
Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1 Guoqiang Jiang, Zhihua Li, Franklin Liu, Journal of Clinical Investigation PharmacotherapyFatty Liver DiseaseCaloric RestrictionObesityMetabolic Syndrome	2005	236

Page 1